DK3520811T3 - Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab - Google Patents
Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab Download PDFInfo
- Publication number
- DK3520811T3 DK3520811T3 DK19158446.5T DK19158446T DK3520811T3 DK 3520811 T3 DK3520811 T3 DK 3520811T3 DK 19158446 T DK19158446 T DK 19158446T DK 3520811 T3 DK3520811 T3 DK 3520811T3
- Authority
- DK
- Denmark
- Prior art keywords
- forceed
- benralizumab
- asthmatics
- procedures
- increase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361864948P | 2013-08-12 | 2013-08-12 | |
| EP14836725.3A EP3033104B1 (en) | 2013-08-12 | 2014-08-07 | Methods for increasing forced expiratory volume in asthmatics using benralizumab |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3520811T3 true DK3520811T3 (da) | 2021-03-22 |
Family
ID=52448838
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19158446.5T DK3520811T3 (da) | 2013-08-12 | 2014-08-07 | Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab |
| DK14836725.3T DK3033104T3 (da) | 2013-08-12 | 2014-08-07 | Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14836725.3T DK3033104T3 (da) | 2013-08-12 | 2014-08-07 | Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9441046B2 (da) |
| EP (3) | EP3520811B1 (da) |
| JP (3) | JP6746496B2 (da) |
| KR (1) | KR102337599B1 (da) |
| CN (2) | CN111588849A (da) |
| AU (2) | AU2014306959B2 (da) |
| BR (1) | BR112016002317A8 (da) |
| CA (1) | CA2917603C (da) |
| CY (2) | CY1122033T1 (da) |
| DK (2) | DK3520811T3 (da) |
| ES (2) | ES2866426T3 (da) |
| HK (2) | HK1222559A1 (da) |
| HR (2) | HRP20190920T1 (da) |
| HU (2) | HUE043497T2 (da) |
| LT (2) | LT3033104T (da) |
| ME (1) | ME03403B (da) |
| MX (2) | MX2016001384A (da) |
| PL (2) | PL3520811T3 (da) |
| PT (2) | PT3033104T (da) |
| RS (2) | RS61565B1 (da) |
| RU (1) | RU2703568C2 (da) |
| SG (1) | SG11201600483QA (da) |
| SI (2) | SI3520811T1 (da) |
| TR (1) | TR201907907T4 (da) |
| WO (1) | WO2015023507A2 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2676333C2 (ru) * | 2013-08-12 | 2018-12-28 | Астразенека Аб | Способы снижения частоты приступов астмы с применением бенрализумаба |
| JP6803229B2 (ja) * | 2013-08-12 | 2020-12-23 | アストラゼネカ アクチボラグ | ベンラリツマブによる喘息症状の改善方法 |
| JP2016534996A (ja) * | 2013-10-15 | 2016-11-10 | メディミューン，エルエルシー | ベンラリズマブを使用して慢性閉塞性肺疾患を治療するための方法 |
| CN105611938A (zh) * | 2013-10-24 | 2016-05-25 | 免疫医疗有限责任公司 | 稳定的水性抗体配制品 |
| TW202110479A (zh) * | 2019-05-16 | 2021-03-16 | 瑞典商阿斯特捷利康公司 | 使用貝那利珠單抗治療增強型患者群體慢性阻塞性肺病之方法 |
| TW202214692A (zh) * | 2020-06-05 | 2022-04-16 | 瑞典商阿斯特捷利康公司 | 治療患有鼻瘜肉的患者的重度氣喘之方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2205007C (en) | 1995-09-11 | 2010-12-14 | Masamichi Koike | Antibody against human interleukin-5 receptor .alpha. chain |
| US6746839B1 (en) * | 1998-01-12 | 2004-06-08 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for an obstructive airway disease |
| ES2420835T3 (es) | 1999-04-09 | 2013-08-27 | Kyowa Hakko Kirin Co., Ltd. | Procedimiento para controlar la actividad de las moléculas inmunofuncionales |
| CA2402477A1 (en) | 2000-02-15 | 2001-08-23 | Kyowa Hakko Kogyo Co., Ltd. | Eosinophil-specific apoptosis inducer |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| US7662925B2 (en) | 2002-03-01 | 2010-02-16 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
| EP1688437A4 (en) | 2003-10-08 | 2007-09-26 | Kyowa Hakko Kogyo Kk | SPECIALLY BINDING ANTIBODY COMPOSITION TO IL-5 RECEPTOR |
| US20060014680A1 (en) | 2004-07-13 | 2006-01-19 | Caiding Xu | Peptides and compounds that bind to the IL-5 receptor |
| AU2006299429B2 (en) | 2005-10-03 | 2012-02-23 | Xencor, Inc. | Fc variants with optimized Fc receptor binding properties |
| EP2068927B1 (en) * | 2007-05-14 | 2015-10-21 | MedImmune, LLC | Methods of reducing eosinophil levels |
| RU2383345C1 (ru) * | 2008-08-07 | 2010-03-10 | Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Росздрава" (ГОУ ВПО "НИЖГМА РОСЗДРАВА") | Способ лечения больных бронхиальной астмой |
| KR101615474B1 (ko) * | 2010-12-16 | 2016-04-25 | 제넨테크, 인크. | Th2 억제에 관한 진단 및 치료 |
| CN102544908B (zh) | 2010-12-17 | 2016-01-06 | 富士康(昆山)电脑接插件有限公司 | 电连接器组件及插头连接器 |
| EP2710370A4 (en) | 2011-05-18 | 2015-01-07 | Medimmune Llc | METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS |
| WO2013066780A2 (en) * | 2011-11-01 | 2013-05-10 | Medimmune, Llc | Methods for reducing the frequency and severity of acute exacerbations of asthma |
| RU2676333C2 (ru) * | 2013-08-12 | 2018-12-28 | Астразенека Аб | Способы снижения частоты приступов астмы с применением бенрализумаба |
| JP6803229B2 (ja) * | 2013-08-12 | 2020-12-23 | アストラゼネカ アクチボラグ | ベンラリツマブによる喘息症状の改善方法 |
-
2014
- 2014-08-07 SG SG11201600483QA patent/SG11201600483QA/en unknown
- 2014-08-07 PL PL19158446T patent/PL3520811T3/pl unknown
- 2014-08-07 DK DK19158446.5T patent/DK3520811T3/da active
- 2014-08-07 CA CA2917603A patent/CA2917603C/en active Active
- 2014-08-07 HU HUE14836725A patent/HUE043497T2/hu unknown
- 2014-08-07 LT LTEP14836725.3T patent/LT3033104T/lt unknown
- 2014-08-07 LT LTEP19158446.5T patent/LT3520811T/lt unknown
- 2014-08-07 TR TR2019/07907T patent/TR201907907T4/tr unknown
- 2014-08-07 ME MEP-2019-137A patent/ME03403B/me unknown
- 2014-08-07 MX MX2016001384A patent/MX2016001384A/es unknown
- 2014-08-07 KR KR1020167006576A patent/KR102337599B1/ko active IP Right Grant
- 2014-08-07 CN CN202010450690.6A patent/CN111588849A/zh active Pending
- 2014-08-07 DK DK14836725.3T patent/DK3033104T3/da active
- 2014-08-07 WO PCT/US2014/050119 patent/WO2015023507A2/en active Application Filing
- 2014-08-07 ES ES19158446T patent/ES2866426T3/es active Active
- 2014-08-07 EP EP19158446.5A patent/EP3520811B1/en active Active
- 2014-08-07 US US14/454,138 patent/US9441046B2/en active Active
- 2014-08-07 PT PT14836725T patent/PT3033104T/pt unknown
- 2014-08-07 HU HUE19158446A patent/HUE053627T2/hu unknown
- 2014-08-07 RU RU2016108809A patent/RU2703568C2/ru active
- 2014-08-07 RS RS20210305A patent/RS61565B1/sr unknown
- 2014-08-07 AU AU2014306959A patent/AU2014306959B2/en active Active
- 2014-08-07 CN CN201480045047.8A patent/CN105451769A/zh active Pending
- 2014-08-07 PT PT191584465T patent/PT3520811T/pt unknown
- 2014-08-07 EP EP20208316.8A patent/EP3875487A1/en active Pending
- 2014-08-07 PL PL14836725T patent/PL3033104T3/pl unknown
- 2014-08-07 JP JP2016534615A patent/JP6746496B2/ja active Active
- 2014-08-07 ES ES14836725T patent/ES2733602T3/es active Active
- 2014-08-07 SI SI201431795T patent/SI3520811T1/sl unknown
- 2014-08-07 EP EP14836725.3A patent/EP3033104B1/en active Active
- 2014-08-07 RS RS20190556A patent/RS58711B1/sr unknown
- 2014-08-07 SI SI201431191T patent/SI3033104T1/sl unknown
- 2014-08-07 BR BR112016002317A patent/BR112016002317A8/pt not_active Application Discontinuation
-
2016
- 2016-01-29 MX MX2021003826A patent/MX2021003826A/es unknown
- 2016-09-12 HK HK16110776.1A patent/HK1222559A1/zh unknown
- 2016-12-01 HK HK16113676A patent/HK1225300A1/zh unknown
-
2019
- 2019-05-17 HR HRP20190920TT patent/HRP20190920T1/hr unknown
- 2019-07-03 CY CY20191100700T patent/CY1122033T1/el unknown
-
2020
- 2020-02-21 AU AU2020201277A patent/AU2020201277A1/en not_active Abandoned
- 2020-04-03 JP JP2020067766A patent/JP2020125304A/ja not_active Withdrawn
-
2021
- 2021-03-10 HR HRP20210406TT patent/HRP20210406T1/hr unknown
- 2021-03-24 CY CY20211100261T patent/CY1124399T1/el unknown
-
2022
- 2022-06-07 JP JP2022092222A patent/JP2022120010A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3293183T3 (da) | Hæmmerforbindelser | |
| DK3424599T3 (da) | Filterflakon | |
| BR112014029111A2 (pt) | inalador | |
| DK3520811T3 (da) | Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab | |
| EP2950633A4 (en) | METHODS FOR INDUCING DROUGHT TOLERANCE IN CROPS | |
| CL2014002180A1 (es) | Peptidos antomicrobianos | |
| DK3536339T3 (da) | Fremgangsmåde til forbedring af astmasymptomer ved anvendelse af benralizumab | |
| BR112014032413A2 (pt) | tanque | |
| DK2880164T3 (da) | Glykoproteinhormon langstidsvirkende superagonister | |
| FR2995782B1 (fr) | Sucres anti-pelliculaires | |
| GB201322490D0 (en) | Improvements in or relating to waveguides | |
| GB201321337D0 (en) | Improvements in or relating to stairlifts | |
| GB201316208D0 (en) | Improvements in or relating to optimisation techniques | |
| FR2994157B1 (fr) | Bicyclette convertible en draisienne | |
| GB2521494B (en) | Improvements in or relating to footwear | |
| SG11201508627XA (en) | Peptides binding to parallel-stranded g-quadruplexes | |
| DE112012006431A5 (de) | Filter | |
| GB2518834B (en) | Improvements in or relating to stairlifts | |
| UA26512S (uk) | Банка для кави | |
| UA23701S (uk) | Каністра | |
| UA23700S (uk) | Каністра | |
| UA25319S (uk) | Розгалужувач електричний | |
| UA25320S (uk) | Розгалужувач електричний | |
| ES1075991Y (es) | Arrancahierbas | |
| UA25445S (uk) | Стелаж |